Ptc Therapeutics PTCT
NASDAQ PTCT
$63.46 -0.67 (-1.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ptc Therapeutics (PTCT) Return on Sales [ROS] (2012 - 2026)

Updated

Ptc Therapeutics' Return on Sales [ROS] was 41.32% in Q2 2026, up 60.87 percentage points from -19.54% a year earlier and up 24.83 percentage points from the prior quarter.

Analysis

Ptc Therapeutics (PTCT) Return on Sales [ROS] (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ptc Therapeutics' Return on Sales [ROS] was 12.45% through Jun 30, 2026, down 28.25 percentage points year-over-year; for FY2025, it was 50.09%, up 87.60 percentage points from FY2024.

  • Return on Sales [ROS] has now increased for five consecutive years, with a five-year change of +163.49 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -37.50% in FY2024 (+9.36 pp), -46.86% in FY2023 (+17.16 pp), -64.03% in FY2022 (+5.50 pp) and -69.52% in FY2021 (+43.87 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Sales [ROS] since Q1 2025.
  • Compared with a year earlier, Return on Sales [ROS] was higher in six of the last eight quarters, with an average year-over-year change of +14.66 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2023 (a gain of 121.56 percentage points); the worst was Q4 2024 (a drop of 78.07 percentage points).
  • Per Business Quant data, PTCT's Return on Sales [ROS] in the three quarters before Q2 2026 was 16.50% (Q1 2026), -43.33% (Q4 2025) and 1.43% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Ptc Therapeutics 5.29 Bn -2.47 Bn 340.60 Mn 41.32%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.32%
Mar 31, 2026 16.50%
Dec 31, 2025 -43.33%
Sep 30, 2025 1.43%
Jun 30, 2025 -19.54%
Mar 31, 2025 82.50%
Dec 31, 2024 -76.18%
Sep 30, 2024 -27.70%
Jun 30, 2024 -21.54%
Mar 31, 2024 -21.63%
Dec 31, 2023 1.90%
Sep 30, 2023 -60.11%
Jun 30, 2023 -98.01%
Mar 31, 2023 -53.37%
Dec 31, 2022 -119.67%
Sep 30, 2022 -31.40%
Jun 30, 2022 -55.80%
Mar 31, 2022 -58.17%
Dec 31, 2021 -51.28%
Sep 30, 2021 -67.09%
API Access

Ptc Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PTCT&period=max&api_key=YOUR_API_KEY